Article Text

other Versions

Low cardiac output predicts development of hepatorenal syndrome and survival in patients with cirrhosis and ascites.
  1. Aleksander Krag1,*,
  2. Flemming Bendtsen1,
  3. Jens H Henriksen1,
  4. Soren Moller2
  1. 1 Hvidovre University Hospital, Denmark;
  2. 2 Hvidover Hospital, Denmark
  1. Correspondence to: Aleksander Krag, Gastroenterology 439, Hvidovre University Hospital, Kettegaard Alle 30, Hvidovre, 2650, Denmark; aleksanderkrag{at}


Objectives: Recent studies suggest that cardiac dysfunction precedes development of the hepatorenal syndrome. In this follow-up study, we aimed to investigate the relation between cardiac- and renal function in patients with cirrhosis and ascites and the impact of cardiac systolic function on survival.

Patients and design: Twenty-four patients with cirrhosis and ascites were included. Cardiac function was investigated by gated myocardial perfusion imaging (MPI) for assessment of cardiac index (CI) and cardiac volumes. The renal function was assessed by determination of glomerular filtration rate (GFR) and renal blood flow (RBF) and the patients were followed-up for 12 months.

Results: In patients with a CI below 1.5 L/min/m2 on MPI, GFR was lower (39±24 vs. 63±23 mL/min, p=0.03), RBF was lower (352±232 vs. 561±229 mL/min, p=0.06), and serum creatinine was higher (130±46 vs. 78±29 µmol/L, p<0.01). The number of patients who developed hepatorenal syndrome type 1 within 3 months was higher in the group with low CI than in the high CI group (43% vs. 5%, p=0.04). Patients with the lowest CI (N=8) had significantly poorer survival at 3, 9, and 12 months compared to those with a higher CI (N=16), p<0.05. In contrast, the MELD score failed to predict mortality in these patients.

Conclusions: The development of renal failure and poor outcome in patients with advanced cirrhosis and ascites seem to be related to a cardiac systolic dysfunction. Other parameters may be more important than MELD score to predict prognosis.

Statistics from


    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Linked Articles

    • Digest
      BMJ Publishing Group Ltd and British Society of Gastroenterology